MedCom has been founded in 1997 and is an entirely privately-owned company. We offer innovative & advanced imaging-based products with emphasis on cancer treatment and interventional navigation. All our products are either dedicated to therapy or are motivated by treatment procedures. As an OEM/B2B company MedCom’s products are integrated by many world-wide acting medical companies.

Our aim is to pioneer each and every product we are working with. Due to our extensive exchange with top-members of the research community and some of the world-best physicians, we are permanently exposed to new and upcoming medical needs from the field. As examples, we commercially released 3D ultrasound in 1996, irradiation virtual simulation in 1999, HDR brachytherapy as monotherapy in 2002, fusion imaging in 2003, proton verification in 2004 and transperineal prostate fusion-biopsy in 2007. All these – and several other- technologies have been world-wide commercially pioneered by MedCom and belong today to established standard of high-end medical care.

Over the years MedCom has been awarded by several academic and professional awards documenting the appreciation of the community and the quality of our products. MedCom regularly participates ambitious R&D projects funded by the European Commission, the German Ministry of Research etc. Joining such leading-edge R&D projects is part of our strategy of permanent innovation and technical leadership.

MedCom GmbH

Org chart

Teams

Offices